Basics Arcus Biosciences, Inc. IPO Date: March 12, 2018 Sector: Healthcare Industry: Biotech Market Cap: $3.15B Activated in VL: True Average Daily Range Avg Daily Range: $0.58 | 3.00% Avg Daily Range (30 D): $0.50 | 2.42% Avg Daily Range (90 D): $0.40 | 2.61% Institutional Daily Volume Avg Daily Volume: .54M Avg Daily Volume (30 D): 1.53M Avg Daily Volume (90 D): 1.03M Trade Size Avg Trade Size (Sh.): 78 Avg Trade Size (Sh.) (30 D): 72 Avg Trade Size (Sh.) (90 D): 72 Institutional Trades Total Inst.Trades: 2,678 Avg Inst. Trade: $2.36M Avg Inst. Trade (30 D): $3.54M Avg Inst. Trade (90 D): $2.61M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.86M Avg Closing Trade (30 D): $6.25M Avg Closing Trade (90 D): $3.27M Avg Closing Volume: 137.73K     News Dec 2, 2024 @ 3:18 PM Biotech Advances Drive Cancer Research as Global R... Source: Prnewswire Aug 23, 2024 @ 3:47 PM Retinoblastoma Treatment Market to Surpass $2 Bill... Source: Researchandmarkets.Com Jul 8, 2024 @ 9:00 PM Cracking The Code: Understanding Analyst Reviews F... Source: Benzinga Insights, Benzinga Staff Writer Jun 7, 2024 @ 2:55 PM Is The Options Market Predicting a Spike In Arcus ... Source: Zacks Equity Research Jun 3, 2024 @ 5:59 PM Gilead (GILD), RCUS Announce Data From Colorectal ... Source: Zacks Equity Research Financials   TTM Q3 2025 Q2 2025 Basic EPS $-3.44 $-1.27 $ Diluted EPS $-3.44 $-1.27 $ Revenue $ 240M $ 26M $ 160M Gross Profit $ $ $ Net Income / Loss $ -341M $ -135M $ M Operating Income / Loss $ -375M $ -142M $ -8M Cost of Revenue $ $ $ Net Cash Flow $ 37M $ -10M $ 56M PE Ratio